Dr. Stephen Hoge, Moderna’s head of R&D, joined the Vanguards of Health Care podcast to share his insights on the company’s groundbreaking work in messenger RNA. In this episode, Dr. Hoge and Bloomberg Intelligence’s Sam Fazeli take listeners into an in-depth conversation on how Covid was just the start of using mRNA as a way of treating disease. They also discuss Moderna’s cancer trials and its approach to rare diseases. 

See omnystudio.com/listener for privacy information.